Orthocell Limited Banner Image

Orthocell Limited

  • Ticker OCC
    Exchange ASX More
  • Industry Biotechnology More
  • Sector Healthcare More
Orthocell Limited Logo Image
  • 11-50 Employees
  • Based in Murdoch, Australia
Orthocell Limited, a regenerative medicine company, develops and commercializes cell therapies and biological medical devices for the repair and regeneration of human tendon, bone, nerve, and cartilage defects in Australia and internationally. The company's principal products include CelGro, a naturally derived collagen medical device for use in multiple indications to augment the surgicalMore repair of tendons, peripheral nerves, bones, and articular cartilage; and Ortho-ATI, a cell therapy for treatment of chronic tendon injuries. It also provides Ortho-ACI, an autologous chondrocyte implantation for the treatment of symptomatic defects of the articulating cartilage of the joints, primarily in the knee and ankle. In addition, the company develops Striate+ for use in bone and soft tissue repair; SMRT Graft for use in to augment repair of rotator cuff tendinopathy and tear; and Remplir, a nerve wrap. Orthocell Limited was incorporated in 2006 and is based in Murdoch, Australia.
4.8 / 5.0 (136)

Orthocell Limited reports have an aggregate usefulness score of 4.8 based on 136 reviews.

Orthocell Limited

Most Recent Annual Report

Orthocell Limited
MOST RECENT 2022 Annual Report

Older/Archived Annual Reports

Orthocell Limited Logo Image

Rate This Report

Your vote helps our reports be more useful
Rating Saved!

Thank you for your feedback!